Financial Performance - The company's operating revenue for the third quarter was CNY 456,489,529.90, a decrease of 8.81% compared to the same period last year[4]. - The total profit for the third quarter increased by 50.78% to CNY 29,591,543.94, primarily due to concentrated deliveries of terminal products[8]. - The net profit attributable to shareholders was CNY 3,326,363.19, reflecting a significant increase of 643.67% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY -570,575.24, a decrease of 177.07% compared to the previous year[4]. - The basic earnings per share for the third quarter was CNY 0.0035, an increase of 766.68% year-on-year[4]. - Total operating revenue for the first three quarters of 2025 was CNY 1,243,982,357.49, a decrease of 20% compared to CNY 1,553,940,066.62 in the same period of 2024[18]. - Net profit for the first three quarters of 2025 was CNY 11,211,867.10, a significant decline from CNY 94,200,550.31 in the same period of 2024[19]. - The company reported a total profit of CNY 23,838,343.00 for the first three quarters of 2025, a decrease from CNY 137,386,762.04 in the same period of 2024[18]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 5,949,787,628.90, a slight decrease of 0.21% from the end of the previous year[5]. - The company's current assets totaled RMB 4,649,778,569.98, an increase of 2.02% from RMB 4,557,280,271.89 in the previous period[15]. - Total liabilities rose to RMB 2,474,801,840.68 from RMB 2,371,793,920.30, indicating an increase of about 4.3%[17]. - The company's equity attributable to shareholders decreased to RMB 2,598,172,858.29 from RMB 2,638,144,431.85, a decline of approximately 1.5%[17]. - The non-current assets totaled RMB 1,300,009,058.92, down from RMB 1,405,110,955.81, a decrease of approximately 7.5%[16]. Cash Flow - The company reported a net cash flow from operating activities of CNY -41,261,964.05 for the year-to-date period[4]. - The company reported a net cash outflow from operating activities of CNY -41,261,964.05 for the first three quarters of 2025, compared to CNY -305,927,259.26 in 2024, indicating an improvement in cash flow[21]. - Cash and cash equivalents at the end of the third quarter of 2025 stood at CNY 1,963,497,411.62, slightly down from CNY 1,971,186,975.78 at the end of 2024[22]. - The company achieved cash inflow from operating activities totaling CNY 1,730,047,383.85, compared to CNY 1,673,977,289.50 in the previous year, marking an increase of about 3.3%[21]. - Investment activities generated a net cash inflow of CNY 7,266,077.08 in the first three quarters of 2025, compared to a net cash outflow of CNY -30,271,404.35 in 2024[22]. - The company incurred a total of CNY 100,244,826.17 in cash outflows from financing activities in 2025, down from CNY 119,811,344.02 in 2024, indicating a reduction of approximately 16%[22]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 79,048[11]. - The largest shareholder, the State Sports General Administration Sports Fund Management Center, held 19.49% of the shares[11]. - The company has not reported any significant changes in its major shareholders or their participation in financing activities[12]. Inventory and Receivables - Cash and cash equivalents decreased to RMB 2,025,718,387.95 from RMB 2,097,890,132.87, reflecting a decline of approximately 3.3%[15]. - Accounts receivable decreased significantly to RMB 184,170,915.00 from RMB 257,786,966.66, a drop of about 28.5%[15]. - Inventory increased to RMB 1,542,517,401.31, up from RMB 1,334,125,882.54, representing a growth of approximately 15.6%[15]. - The company reported a significant increase in contract liabilities to RMB 891,003,085.77, up from RMB 670,160,449.59, reflecting a growth of about 32.9%[16].

Financial Performance - The company's revenue for Q3 2025 was CNY 336,038,374.58, representing a year-on-year increase of 0.80%[4] - Total profit for the period decreased by 38.54% to CNY 29,605,030.93 compared to the same period last year[9] - Net profit attributable to shareholders was CNY 29,431,529.17, down 28.80% year-on-year[4] - Basic earnings per share decreased by 30.00% to CNY 0.07[5] - Total operating revenue for the first three quarters of 2025 was CNY 907,110,655.28, a decrease of 1.05% compared to CNY 922,078,655.61 in the same period of 2024[18] - Net profit for the first three quarters of 2025 was CNY 72,923,321.09, down 27.8% from CNY 100,993,185.97 in the previous year[20] - Earnings per share (EPS) for the first three quarters of 2025 was CNY 0.18, compared to CNY 0.24 in the same period of 2024[20] - Total profit for the first three quarters of 2025 was CNY 76.09 million, down 22.14% from CNY 97.83 million in the first three quarters of 2024[27] Expenses and Costs - Research and development expenses totaled CNY 13,646,628.03, accounting for 4.06% of revenue, a decrease of 0.87 percentage points[5] - Total operating costs increased to CNY 830,855,948.57, up 2.68% from CNY 814,309,359.50 year-over-year[18] - Research and development expenses for the first three quarters of 2025 were CNY 37,990,356.53, a decrease of 7.3% compared to CNY 41,109,773.80 in 2024[18] - Research and development expenses for the first three quarters of 2025 were CNY 31.67 million, a decrease of 8.00% from CNY 34.74 million in the first three quarters of 2024[27] - The company's sales expenses increased to CNY 37.81 million in the first three quarters of 2025, up 3.39% from CNY 36.57 million in the same period of 2024[27] Assets and Liabilities - Total assets increased by 7.91% to CNY 2,211,623,060.82 compared to the end of the previous year[5] - The company's total assets as of September 30, 2025, amount to ¥2,211,623,060.82, an increase from ¥2,049,432,035.11 as of December 31, 2024[14] - Current assets total ¥1,548,150,433.50, down from ¥1,637,394,342.83 in the previous period[15] - Total liabilities increased to ¥533,622,924.76 from ¥473,156,353.88[16] - The company's equity increased to ¥1,677,000,136.06 from ¥1,576,275,681.23[16] - The company's total assets and equity increased to CNY 2,211,623,060.82 and CNY 1,678,000,136.06 respectively, compared to CNY 2,049,432,035.11 and CNY 1,576,275,681.23 in the previous year[17] - The company’s total liabilities and equity increased by 7.9% year-over-year[17] - The total liabilities increased to ¥387,696,324.41 from ¥322,954,409.42, which is an increase of about 20%[25] - The total equity rose slightly to ¥1,482,257,946.44 from ¥1,477,978,784.01, indicating a marginal increase of around 0.2%[25] Cash Flow - The company reported a cash flow from operating activities of CNY 144,482,414.65, an increase of 13.48% year-to-date[4] - Cash flow from operating activities totaled CNY 789,126,671.65, slightly down from CNY 789,864,610.23 in the previous year[20] - The net cash flow from operating activities increased to ¥144,482,414.65 from ¥127,317,014.95, representing a growth of approximately 13.4% year-over-year[21] - The company reported a net cash outflow from investing activities of CNY 172.72 million in the first three quarters of 2025, compared to a net outflow of CNY 92.83 million in the same period of 2024[30] - The cash and cash equivalents at the end of the first three quarters of 2025 were CNY 623.77 million, an increase from CNY 509.08 million at the end of the same period in 2024[30] - The company's cash flow from operating activities was positive, while both investment and financing activities resulted in net outflows, indicating a need for strategic financial management[21] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,168[11] - The largest shareholder, Hangzhou Industrial Investment Group Co., Ltd., holds 156,000,000 shares, accounting for 36.78% of total shares[11] - The number of shares held by the top 10 shareholders remains unchanged, with no shares lent out through margin trading[13] Market Conditions and Strategic Focus - The decline in profit was attributed to weak market demand and intensified price competition, along with costs from ongoing projects[9] - The company is currently in the cultivation stage of new acquisition projects, which are impacting profitability due to initial investments[9] - The company has not reported any significant changes in operational strategies or new product developments during the reporting period[12] - The company plans to continue focusing on research and development to enhance product offerings and market competitiveness[27]

Financial Performance - The company's operating revenue for the third quarter was ¥967,246,187.20, a decrease of 15.16% compared to the same period last year[4]. - The total profit for the third quarter was a loss of ¥42,457,854.92, representing a decline of 412.60% year-on-year[4]. - The net profit attributable to shareholders for the year-to-date period was a loss of ¥6,402,551.59, down 102.35% compared to the previous year[4]. - The basic earnings per share for the third quarter was -¥0.0229, a decrease of 475.41% year-on-year[5]. - Total operating revenue for the first three quarters of 2025 was CNY 3,243,549,675.86, a decrease of 22.0% compared to CNY 4,158,019,658.36 in the same period of 2024[20]. - Net profit for the first three quarters of 2025 was CNY 36,478,090.59, a decline of 89.1% compared to CNY 335,216,190.10 in 2024[21]. - Earnings per share for the first three quarters of 2025 was CNY 0.0198, down from CNY 0.2042 in the same period of 2024[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥11,211,153,280.91, an increase of 2.20% from the end of the previous year[5]. - As of September 30, 2025, the company's total assets reached RMB 11,211,153,280.91, an increase from RMB 10,969,955,712.53 at the end of 2024[15]. - The total liabilities of the company as of September 30, 2025, were not explicitly stated but are implied to be managed effectively given the increase in assets[15]. - Total liabilities increased to CNY 2,907,298,538.56 in 2025 from CNY 2,772,573,621.36 in 2024, reflecting a growth of 4.8%[18]. - Total equity increased to CNY 8,303,854,742.35 in 2025 from CNY 8,197,382,091.17 in 2024, representing a growth of 1.3%[18]. Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥461,252,163.81, an increase of 4.03% compared to the previous year[4]. - Cash inflow from operating activities for the first three quarters of 2025 was approximately $2.94 billion, compared to $3.95 billion in the same period of 2024, representing a decrease of about 25.5%[23]. - Net cash flow from operating activities for the first three quarters of 2025 was approximately $461.25 million, slightly up from $443.40 million in 2024, indicating a marginal increase of about 4%[24]. - Total cash outflow from operating activities increased to approximately $2.48 billion in 2025 from $3.51 billion in 2024, reflecting a decrease of about 29.3%[24]. - Cash inflow from investment activities was approximately $10.04 million in 2025, down from $24.31 million in 2024, showing a decline of about 58.7%[24]. - Net cash flow from investment activities was negative at approximately -$305.05 million in 2025, compared to -$550.64 million in 2024, indicating an improvement of about 44.6%[24]. - Cash inflow from financing activities totaled approximately $335.84 million in 2025, compared to $440.44 million in 2024, representing a decrease of about 23.7%[24]. - Net cash flow from financing activities was approximately $34.76 million in 2025, a significant improvement from a negative $107.23 million in 2024[24]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 37,510[12]. - The largest shareholder, Hunan Salt Industry Group Co., Ltd., holds 29.73% of the shares[12]. - The company maintains a controlling stake of 51% in Xue Tian New Materials post-capital increase, ensuring operational control[14]. Strategic Initiatives - The company plans to introduce external investors, including Jianxin Financial Asset Investment Co., Ltd., with an investment of RMB 30,000 million in its subsidiary, Xue Tian New Materials, to enhance capital structure[14]. - The company reported a significant decline in profitability due to a sharp drop in market prices for some of its main products[9]. Research and Development - Research and development expenses for the first three quarters of 2025 were CNY 147,957,681.47, a decrease of 14.4% from CNY 172,751,618.18 in 2024[20].

Financial Performance - The company's operating revenue for Q3 2025 was ¥97,517,853.60, a decrease of 31.85% compared to the same period last year[5] - The net profit attributable to shareholders was -¥42,298,129.90, down 24.31% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥46,426,684.45, a decrease of 31.71% compared to the previous year[5] - The company reported a basic and diluted earnings per share of -¥0.1035, down 24.29% year-on-year[5] - Total operating revenue for the current period was ¥427,447,670.70, a decrease of 5.9% from ¥452,854,778.33 in the previous period[32] - Net profit for the current period was a loss of ¥28,110,025.84, compared to a loss of ¥33,495,007.46 in the previous period, showing an improvement of 16.5%[33] - The basic and diluted earnings per share were both -0.0688, an improvement from -0.0820 in the previous period[34] Research and Development - R&D expenses for the period amounted to ¥35,864,500, an increase of 30.24% year-on-year, indicating increased investment in research and development[16] - Research and development expenses increased to ¥35,864,548.44, up 30.3% from ¥27,536,555.06 in the previous period[33] Cash Flow and Liquidity - The cash flow from operating activities showed a net outflow of -¥192,905,946.34, a decrease of 24.47% compared to the previous year[5] - Cash inflow from operating activities totaled ¥529,105,486.26, down 18.8% from ¥651,456,119.47 in the previous period[35] - The net cash outflow from operating activities was -$192.91 million, compared to -$154.98 million in the previous period, indicating a decline in operational cash flow[36] - The ending balance of cash and cash equivalents was $449.60 million, up from $433.79 million in the previous period, indicating a slight increase in liquidity[36] - The company reported a total cash outflow of $722.01 million from operating activities, down from $806.43 million in the previous period, indicating improved operational efficiency[36] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,818,829,193.06, a decrease of 8.24% from the end of the previous year[5] - The balance of inventory at the end of the period was ¥133,042,400, an increase of 89.00% compared to the beginning of the period, due to ongoing projects[9] - The balance of other receivables decreased by 52.60% to ¥48,857,200, primarily due to a reduction in accounts receivable[8] - Total current liabilities decreased to ¥428,087,253.87 from ¥552,225,027.91, a decline of approximately 22.4%[29] - Non-current assets decreased to ¥347,397,858.48 from ¥412,034,087.32, a decrease of about 15.7%[29] - Total liabilities amounted to ¥465,751,589.44, down from ¥596,892,000.60, indicating a reduction of 22%[30] - Total equity attributable to shareholders of the parent company was ¥1,353,077,603.62, slightly down from ¥1,385,273,114.01[30] Shareholder Information - Total number of common shareholders at the end of the reporting period is 72,657[25] - The largest shareholder, China First Automobile Group Co., Ltd., holds 48.67% of shares, totaling 198,854,344 shares[25] Government Support - The company received government subsidies amounting to ¥4,612,798.20 during the period, contributing to its financial performance[6] Other Information - The company has not disclosed any new product developments or market expansion strategies in the current reporting period[26] - The financial report for the third quarter was not audited, which may affect the reliability of the reported figures[38]

金龙羽集团股份有限公司 2025 年第三季度报告 3.第三季度财务会计报告是否经过审计 □是 否 1 金龙羽集团股份有限公司 2025 年第三季度报告 证券代码：002882 证券简称：金龙羽 公告编号：2025-075 金龙羽集团股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 期增减 | | 比上年同期增减 | | 营业收入（元） | 1,576,847,201.98 | 54.63% | ...

江苏恩华药业股份有限公司 2025 年第三季度报告 证券代码：002262 证券简称：恩华药业 公告编号：2025-053 江苏恩华药业股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 江苏恩华药业股份有限公司 2025 年第三季度报告 单位：元 项目 本报告期金额 年初至报告期期末金额 说明 非流动性资产处置损益（包 括已计提资产减值准备的冲 销部分） 22,161.91 -319,529.13 计入当期损益的政府补助 （与公司正常经营业务密切 相关、符合国家政策规定、 按照确定的标准享有、对公 司损益产生持续影响的政府 补助除外） 458,808.32 1,566,456.32 除上述各项之外的 ...

Financial Performance - The company's operating revenue for the third quarter reached CNY 334,788,395.50, an increase of 4.49% compared to the same period last year[4] - The total profit for the quarter was CNY 68,257,107.80, reflecting a growth of 16.95% year-over-year[4] - The net profit attributable to shareholders was CNY 55,120,245.78, which is a 12.14% increase compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was CNY 55,145,026.34, up by 12.94% year-over-year[4] - Basic earnings per share for the quarter were CNY 0.39, an increase of 11.43% compared to the same period last year[5] - The diluted earnings per share also stood at CNY 0.39, reflecting an increase of 11.43% year-over-year[5] - Total operating revenue for the first three quarters of 2025 reached ¥1,117,359,443.31, an increase of 8.25% compared to ¥1,032,254,051.86 in the same period of 2024[19] - Operating profit for the first three quarters of 2025 was ¥196,555,710.17, up 23.31% from ¥159,390,162.49 in the first three quarters of 2024[20] - Net profit attributable to shareholders of the parent company for the first three quarters of 2025 was ¥157,667,263.54, representing a 20.51% increase from ¥130,852,963.62 in the same period of 2024[20] - Earnings per share for the first three quarters of 2025 were ¥1.11 (basic) and ¥1.12 (diluted), compared to ¥0.92 for both in the first three quarters of 2024[21] Cash Flow - The cash flow generated from operating activities for the year-to-date period was CNY 233,339,630.11, showing a significant increase of 50.21%[4] - Cash inflow from operating activities for the first three quarters of 2025 was ¥1,225,996,189.20, an increase from ¥1,068,509,841.35 in the same period of 2024[23] - The net cash flow from operating activities was $233,339,630.11, an increase of 50% compared to $155,344,046.07 in the previous period[24] - Cash outflows from operating activities totaled $992,656,559.09, up from $913,165,795.28, indicating a 9% increase[24] - The company reported a cash inflow of $11,400,138.41 from investment income, more than double the $5,431,503.10 received previously[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,380,163,420.26, a decrease of 0.95% from the previous year-end[5] - The equity attributable to shareholders was CNY 1,523,434,580.74, showing a slight decrease of 0.07% compared to the previous year-end[5] - Current assets totaled RMB 530,374,470.59, down from RMB 599,972,735.72 in the previous year, indicating a decrease of approximately 11.6%[15] - Total liabilities were RMB 712,708,781.26, down from RMB 742,295,754.94, indicating a reduction of approximately 4%[16] - The company's equity totaled RMB 1,667,454,638.00, reflecting a decrease from RMB 1,660,702,910.49[16] Changes in Financial Position - The company's cash and cash equivalents were RMB 230,996,806.55, compared to RMB 268,284,043.72 at the end of 2024, reflecting a decline of about 13.9%[14] - Accounts receivable increased to RMB 160,592,911.51 from RMB 154,620,460.58, showing a growth of approximately 3.3%[14] - Inventory decreased to RMB 64,537,479.50 from RMB 81,084,974.82, representing a decline of about 20.3%[15] - The company reported a significant reduction in employee compensation liabilities, which decreased to RMB 10,059,458.95 from RMB 20,129,225.00, a drop of about 50%[16] - The long-term borrowings were recorded at RMB 14,250,000.00, which is a new entry compared to the previous period[16] Strategic and Operational Insights - The company has not reported any significant changes in shareholder structure or major strategic shifts during the reporting period[12] - The company plans to implement new accounting standards starting in 2025, which may affect future financial reporting[26] Other Financial Metrics - The weighted average return on equity increased by 0.35 percentage points to 3.70% for the quarter[5] - The company reported a credit impairment loss of ¥17,951,610.51 in the first three quarters of 2025, compared to a loss of ¥669,054.01 in the same period of 2024[20] - Other comprehensive income after tax for the first three quarters of 2025 was -¥2,222,205.06, compared to ¥2,885,517.67 in the first three quarters of 2024[21] - The total equity attributable to shareholders of the parent company was ¥1,523,434,580.74 as of the end of the reporting period, slightly down from ¥1,524,434,294.39 at the end of the previous period[18] - The company’s total liabilities and equity amounted to ¥2,380,163,420.26, a decrease from ¥2,402,998,665.43 in the previous period[18]

Financial Performance - The company's operating revenue for the third quarter reached ¥350,809,483.97, representing a year-on-year increase of 57.69%[5] - The net profit attributable to shareholders decreased by 17.79% to ¥21,236,808.48, while the net profit after deducting non-recurring gains and losses fell by 13.90% to ¥14,165,824.94[5] - The company reported a basic earnings per share of ¥0.0089, down 17.59% compared to the same period last year[5] - Total operating revenue for the current period reached ¥909,939,199.32, a significant increase from ¥649,514,002.28 in the previous period, representing an increase of approximately 40%[19] - Net profit for the current period was ¥92,646,869.09, compared to ¥40,777,162.15 in the previous period, reflecting an increase of approximately 127%[20] - Earnings per share (EPS) for the current period was ¥0.0345, compared to ¥0.0149 in the previous period, representing an increase of approximately 132%[21] - The total comprehensive income for the current period was ¥92,646,869.09, compared to ¥39,981,868.12 in the previous period, indicating an increase of approximately 132%[21] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥2,963,014,483.92, reflecting a 3.50% increase compared to the end of the previous year[5] - The company’s total equity attributable to shareholders increased by 2.95% to ¥2,265,356,898.29 compared to the end of the previous year[5] - The company’s total current assets amount to ¥2,253,991,373.73, an increase from ¥2,088,071,071.46 at the beginning of the period[17] - Total liabilities are reported at ¥505,835,752.15, an increase from ¥476,713,332.82[17] - Total liabilities amounted to ¥598,717,721.78, up from ¥576,236,051.39, indicating a growth of about 4%[18] Cash Flow - The cash flow from operating activities showed a significant decline, with a net outflow of ¥84,750,250.17, down 204.12% year-on-year[5] - The net cash flow from operating activities was negative at -¥84,750,250.17, a decline from a positive cash flow of ¥81,397,433.71 in the previous period[22] - The net cash flow from investment activities increased by ¥17,513.66 million, mainly due to the net recovery from the sale of securities investments and financial institution wealth management products[11] - Net cash flow from investment activities was $73.72 million, a significant improvement from a net outflow of $101.42 million in the previous period[23] - The ending balance of cash and cash equivalents was $72.86 million, down from $78.71 million at the end of the previous period, indicating a reduction in liquidity[23] Research and Development - The company’s R&D expenses increased by 38.58% year-on-year, amounting to an increase of ¥828.52 million, primarily due to increased projects in the machinery manufacturing sector[10] - Research and development expenses increased to ¥29,758,781.65 from ¥21,473,603.96, marking a rise of about 38%[19] Shareholder Information - Total number of common shareholders at the end of the reporting period is 51,625[13] - The largest shareholder, Jiangyin Chengbang Enterprise Management Development Center, holds 29.02% of shares, totaling 689,798,380 shares[13] Inventory and Receivables - Accounts receivable increased to ¥434,163,214.49 from ¥305,069,910.34, reflecting a growth of approximately 42.2%[16] - Inventory at the end of the period is ¥397,535,063.46, up from ¥379,833,960.46, indicating a rise of about 4.6%[16] Financial Expenses - The company’s financial expenses rose by 272.64% year-on-year, primarily due to increased interest expenses[10]

哈药集团股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1、公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 证券代码：600664 证券简称：哈药股份 哈药集团股份有限公司 2025 年第三季度报告 2、公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信 息的真实、准确、完整。 3、第三季度财务报表是否经审计 | | | 上年度末增减 变动幅度(%) | | | --- | --- | --- | --- | | 总资产 | 14,080,865,475.74 | 14,615,758,011.08 | -3.66 | | 归属于上市公司股东的所有者 | 5,657,894,078.79 | 5,349,779,547.13 | 5.76 | | 权益 | | | | 注："本报告期"指本季度初至本季度末 3 个月期间，下同。 （二） 非经常性损益项目和 ...

Financial Performance - The company's revenue for Q3 2025 reached ¥139,312,848.65, an increase of 11.27% compared to the same period last year[4] - Net profit attributable to shareholders was ¥31,668,724.25, representing a significant increase of 339.92% year-on-year[4] - The net profit excluding non-recurring gains and losses was ¥25,240,026.54, showing a remarkable growth of 5,439.21% compared to the previous year[4] - Basic earnings per share for the period was ¥0.26, up 333.33% year-on-year[4] - Total operating revenue increased to ¥487,715,534.85, up 25.9% from ¥387,196,007.94 in the previous period[18] - Operating profit rose significantly to ¥120,178,239.04, compared to ¥45,981,613.25 in the prior period, marking a growth of 161.5%[19] - Net profit for the period reached ¥103,429,320.45, a substantial increase of 63.1% from ¥39,290,561.22 year-over-year[19] - Earnings per share (EPS) improved to ¥0.86, up from ¥0.33, reflecting a growth of 160.6%[19] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥2,325,697,571.21, reflecting a 2.75% increase from the end of the previous year[4] - The total assets of the company amounted to ¥2,325,697,571.21, compared to ¥2,263,389,145.02, marking an increase of about 2.8%[16] - The company's total liabilities increased to ¥121,449,743.86 from ¥114,569,854.99, which is an increase of approximately 6.5%[16] - Total current assets reached ¥1,674,380,425.62, up from ¥1,503,877,958.89, reflecting a growth of approximately 11.3%[14] - Non-current assets decreased to ¥651,317,145.59 from ¥759,511,186.13, showing a decline of about 14.2%[16] - The company’s total equity remained stable at ¥120,446,669.00[16] Cash Flow and Investments - Cash flow from operating activities for the year-to-date was ¥149,201,647.03, an increase of 13.10%[4] - Cash flow from operating activities generated ¥149,201,647.03, an increase of 13.1% compared to ¥131,914,298.83 in the previous period[21] - The company experienced a net cash inflow from investment activities of ¥125,851,446.54, compared to ¥101,423,525.56 in the previous period, an increase of 24.1%[21] - Cash and cash equivalents increased to ¥415,345,384.91 from ¥191,177,985.31, representing a growth of approximately 117.5%[14] - Cash and cash equivalents at the end of the period totaled ¥415,345,384.91, down from ¥644,881,050.63, a decrease of 35.5%[21] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,088[10] - Kingchem (China) holds 48.66% of the shares, making it the largest shareholder[10] Other Financial Metrics - The company reported a significant increase in receivables, with notes receivable rising by 108.59% to ¥60,144,210.32 due to increased revenue[8] - The company experienced a 941.95% increase in taxes payable, amounting to ¥2,895,967.10, attributed to the growth in revenue scale[8] - Accounts receivable rose to ¥80,233,518.31 from ¥74,601,150.11, indicating an increase of about 7.2%[14] - The company’s inventory decreased to ¥147,484,364.70 from ¥194,971,270.02, representing a decline of approximately 24.3%[14] - The company held short-term borrowings of ¥0, indicating no reliance on short-term debt[16] - The company’s deferred income tax liabilities slightly increased to ¥10,047,928.15 from ¥10,031,070.23, reflecting a marginal increase of about 0.2%[16] - The company reported a decrease in research and development expenses to ¥21,034,142.35 from ¥24,554,055.59, indicating a reduction of 14.3%[18] - Other comprehensive income after tax decreased to -¥3,465,005.78 from -¥1,484,846.41, reflecting a decline of 133.4%[19] Accounting Standards - The third quarter financial report of Jinkai (Liaoning) Life Science Technology Co., Ltd. has not been audited[23] - The new accounting standards will be implemented starting from 2025, affecting the financial statements from the beginning of that year[22]